Progenics Pharmaceuticals Inc. (PGNX)

[chemist72]

You might be interested in the following info on PGNX:

According to Brean Capital analyst Jonathan Aschoff, the limited bioavailability of oral Relistor compared to Relistor SQ, which has been on the market for eight years, should get the FDA around any safety concerns as blood levels are vastly lower with the oral. The FDA asked for the pivotal oral Relistor trial to demonstrate that the pill had a higher response rate and greater tolerability than the currently approved injection, and the trial delivered on both.

from:

http://www.investopedia.com/articles/insights/060216/important-catalysts-approaching-these-biotechs.asp